Rationale: Hemizygous deficiency of the transcription factor Krü ppel-like factor 2 (KLF2) has been shown previously to augment atherosclerosis in hypercholesterolemic mice. However, the cell type responsible for the increased atherosclerosis due to KLF2 deficiency has not been identified. This study examined the consequence of myeloid cell-specific KLF2 inactivation in atherosclerosis.
T he zinc finger transcription factor, Krüppel-like factor 2 (KLF2), is required for vascular integrity. Mice lacking KLF2 fail to develop beyond embryonic day 12.5 to 14.5, 1,2 and animals exhibit severe hemorrhaging, endothelialmediated defects in blood vessel wall integrity, and abnormalities in the tunica media with decreased deposition of extracellular matrix surrounding the vessel. 1 The embryonic lethality observed in whole-animal knockouts of KLF2 occurs with endothelial specific knockouts of KLF2 but not with smooth muscle loss of KLF2, indicating that endothelial expression of KLF2 is necessary for vascular function. 3 Mice lacking endothelial KLF2 die in utero due to high cardiac output resulting from a loss of peripheral vascular resistance. 3 
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The importance of KLF2 in vascular development has led to the hypothesis that KLF2 may also have a protective role in the vascular system under pathological conditions. This hypothesis is supported by the finding that mice lacking 1 copy of the KLF2 gene exhibit increased atherosclerosis when mated with apoE-deficient mice and fed a high fat and cholesterol diet. 4 However, as these mice have reduced KLF2 levels in all cells, and the pathogenesis of atherosclerotic lesions includes vascular endothelial and smooth muscle cell abnormalities as well as infiltration and proinflammatory activation of circulating leukocytes, the importance of KLF2 expression in each of these cell types toward atheroprotection has not been completely elucidated.
In the vascular endothelium, KLF2 is expressed in areas of high laminar flow but at low levels where little shear stress occurs such as at bifurcations and bends. 5 The shear stress element of the KLF2 gene has been identified 6 and shown to bind several transcription factors, [7] [8] [9] with MEF2 acting as one of the factors that links shear stress with KLF2 expression. 9 Under laminar flow conditions, KLF2 expression is induced, 10, 11 leading to the downregulation of inflammatory genes such as vascular cell adhesion molecule and E-selectin and the upregulation of vascular protective genes such as endothelial nitric oxide synthase. [12] [13] [14] Several antithrombotic genes are also upregulated including thrombomodulin and tissue plasminogen activator, whereas plasminogen activator inhibitor-1, protease activated receptor 1, and tissue factor are downregulated. 4,6,10 -14 Two of these genes, endothelial nitric oxide synthase and thrombomodulin, have been shown to be KLF2 regulated and the promoter regions that bind KLF2 have been identified. [12] [13] [14] These results indicate that KLF2 expression in endothelial cells protects against endothelial activation by modulating the expression of these genes.
In the peripheral circulation, KLF2 is expressed in mature thymocytes, naive T cells, and memory T cells as well as in cells from the myeloid lineage. In the hematopoietic T cells, KLF2 binds to and transactivates the promoter for sphingosine-1-phosphate receptor-1 to promote thymocyte emigration and recirculation through peripheral lymphoid organs. 15 KLF2 has also been shown to be involved in monocyte differentiation, with diminished expression on monocyte differentiation into macrophages. 16 The expression of KLF2 is required to maintain immune cell quiescence, but its expression in both T cells and monocytes is suppressed during cell activation and inflammation. 16 -18 Overexpression of KLF2 inhibits immune cell activation and the expression of inflammatory genes is repressed. 16 Interestingly, KLF2 expression can be induced by statin treatment, 18 suggesting that the lipid-independent atheroprotective effects of statin therapy may be due to induction of KLF2 gene expression.
Another related transcription factor, KLF4, has also been shown to play a role in the proinflammatory response of macrophages. 19 Interestingly, KLF4-deficient progenitor cells of the myeloid lineage differentiate preferentially into granulocytes at the expense of monocytes, whereas overexpression of KLF4 results in almost exclusive differentiation of these progenitor cells into monocytes. 20 Because neutrophil infiltration is an early event of atherogenesis and the depletion of neutrophils reduces atherosclerotic lesion size, 21 expression of these Krüppel-like factors in myeloid cells may significantly impact on atherosclerosis development and progression. To explore the role of myeloid cell KLF2 in lesion formation, mice were developed in which KLF2 was deleted in myeloid cells. The myeloid KLF2-deficient mice were then placed on an Ldlr Ϫ/Ϫ background and fed a high fat diet. The resulting animals exhibited an increase in vascular lesion formation, emphasizing the importance in myeloid KLF2 in this process.
Methods
An expanded Methods section is available in the Online Data Supplement.
The Klf2 fl/lfl mice in C57BL/6 background were generated by homologous recombination using the strategy described in the Online Supplemental Methods and shown schematically in Figure  1A . 
Results

Development of Myeloid-Specific KLF2-Deficient Mice
The approach for determining whether KLF2 in myeloid cells alters the course of vascular lesion formation and atherosclerosis was to develop mice that lack this transcription factor in the myeloid cell lineage. This was accomplished by mating mice carrying conditional Klf2 allele in which a portion of the Figure 1D and 1E). Therefore, these mice can be referred to as myeloid-specific Klf2 knockout (myeKlf2 Ϫ/Ϫ ) mice. The Klf2 fl/fl mice without cre recombinase expression are referred to as myeKlf2 ϩ/ϩ mice. The inactivation of KLF2 in myeloid cells did not influence KLF4 gene expression in macrophages of myeKlf2 ϩ/ϩ and myeKlf2 Ϫ/Ϫ mice (Online Figure I ). Additionally, KLF4 expression was not detectable in neutrophils of either myeKlf2 ϩ/ϩ or myeKlf2 Ϫ/Ϫ mice.
Myeloid KLF2 Inactivation Reduces Lymphocyte Cell Count and Alters Neutrophil-Lymphocyte Ratio
The influence of myeloid KLF2 expression on leucopoiesis and cell differentiation was examined by comparing total mice. Interestingly, total number of monocytes and granulocytes, including neutrophils, eosinophils, and basophils, was not affected by KLF2 expression. In contrast, total lymphocyte cell count was significantly reduced in myeKlf2 Ϫ/Ϫ mice compared with myeKlf2 ϩ/ϩ mice (Online Figure II, A) . The reduced lymphocyte cell count resulted in alteration in leukocyte cell population with a trend toward higher monocyte:lymphocyte and neutrophil:lymphocyte ratios in myeKlf2 Ϫ/Ϫ mice that did not reach statistical significance (Online Figure II , B and C).
Myeloid KLF2 Inactivation Increases Atherosclerosis in Hypercholesterolemic Mice
Elevation of neutrophil-lymphocyte ratio is an indicator of inflammation and is associated with poor cardiovascular outcome. 22, 23 Although this relationship is generally attributed to inflammation associated with atherosclerosis 24 and inflammation-induced granulopoiesis at the expense of lymphopoiesis, [25] [26] [27] potential direct contribution of elevated neutrophil-lymphocyte ratio toward atherosclerosis has not been explored. Therefore, myeKlf2 Ϫ/Ϫ mice were mated to Ldlr Ϫ/Ϫ mice to generate myeKlf2
flox/flox Ldlr Ϫ/Ϫ mice without the LysM-cre transgene (myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ ) retained normal myeloid Klf2 expression in Ldlr Ϫ/Ϫ background and therefore were used as control. The LysM-cre transgenic mice with normal Klf2 gene expression were not included as controls because numerous studies from several laboratories have reported that myeloid cre recombinase expression in this mouse line has no effect on atherosclerosis lesion area in the aortic roots. 28 -30 The mice were fed a high fat and high cholesterol Westerntype diet for 8 weeks beginning at 6 weeks of age. Plasma cholesterol and triglyceride levels were similar between myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ and myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice under both basal and Western diet feeding conditions (Figure 2A) . However, significant increase in atherosclerosis was observed in the aortic roots in mice with myeloid KLF2 deficiency ( Figure 2B ). The difference in atherosclerotic lesion area was evident when data from both male and female mice were analyzed together ( Figure 2C ). Although lesion areas in male myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ and myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice did not reach statistically significant difference, the difference in lesion area was striking between female myeKlf2 ϩ/ϩ Ldlr
and myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice ( Figure 2D ). The sex difference is not immediately obvious but may be related to the generally more robust atherosclerotic response of female mice compared with male mice, 31, 32 and the effect of KLF2 expression was less evident in mice with less severe atherosclerosis.
KLF2 Deficiency Increases Macrophage Adhesion to Endothelial Cells
The increase in atherosclerosis observed in myeloid KLF2-deficient hypercholesterolemic mice may be due to elevated macrophage inflammation and/or propensity for lipid accumulation in response to atherogenic lipoprotein stimulation. To test these possibilities, bone marrow-derived macrophages from myeKlf2 ϩ/ϩ and myeKlf2 Ϫ/Ϫ mice were incubated with or without lipopolysaccharide (LPS) and interleukin (IL)-4. Both myeKlf2 ϩ/ϩ and myeKlf2 Ϫ/Ϫ macrophages responded to LPS-induced M1 polarization with elevated expression of IL-6, tumor necrosis factor-␣, and inducible nitric oxide synthase (iNOS) (Nos2) ( Figure 3A) . Macrophages from myeKlf2 ϩ/ϩ and myeKlf2 Ϫ/Ϫ mice also responded to IL-4 -induced M2 polarization with elevated expression of Arg-1, Ym1, and Fizz1 ( Figure 3B ). Interestingly, both LPS and IL-4 also increased KLF2 expression in myeKlf2 ϩ/ϩ macrophages, which may explain the lower LPS-induction of iNOS and IL-6 and IL-4-induction of Fizz1 observed in myeKlf2 Ϫ/Ϫ cells. When the thioglycolateelicited peritoneal macrophages were added to endothelial monolayer, more myeKlf2 Ϫ/Ϫ macrophages were found to adhere to endothelial cells in comparison with that observed with myeKlf2 ϩ/ϩ macrophages ( Figure 4A ). Additional experiments revealed no statistically significant difference in neutral lipid accumulation between peritoneal macrophages isolated from myeKlf2 ϩ/ϩ and myeKlf2 Ϫ/Ϫ mice ( Figure 4B ). Taken together, these data indicate that KLF2 deficiency does not alter lipid accumulation in macrophages but may promote 
KLF2 Deficiency Increases Neutrophil Adhesion and Cell Death
Neutrophils from myeKlf2 Ϫ/Ϫ mice were also defective in KLF2 expression compared with neutrophils from myeKlf2 ϩ/ϩ mice ( Figure 1E ). Neutrophils from myeKlf2 Ϫ/Ϫ mice showed elevated CD11b expression during fasting as well as after feeding a lipid-rich meal ( Figure 5A ). Additionally, more myeKlf2 Ϫ/Ϫ neutrophils than myeKlf2 ϩ/ϩ neutrophils were found to adhere to activated endothelial cells ( Figure 5B ), which probably is due to the elevated expression of CD11b in myeKlf2 Ϫ/Ϫ neutrophils. 33 Expression of CD11b in polymorphonuclear leukocytes has also been shown to promote apoptosis. 34, 35 Indeed, fewer myeKlf2 Ϫ/Ϫ neutrophils were found to survive after 24 hours in culture compared with myeKlf2 ϩ/ϩ neutrophils ( Figure 5C ).
Myeloid KLF2 Deficiency Promotes Macrophage and Neutrophil Accumulation and Activity in Atherosclerotic Lesions of Hypercholesterolemic Mice
The increased propensity of myeKlf2 Ϫ/Ϫ macrophage and neutrophil adherence to endothelial cells observed in vitro suggested that increased atherosclerosis observed in myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice may be due to elevated infiltration of these inflammatory cells to the lesion area. Analysis of atherosclerotic lesions in female myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ and myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice did reveal statistically significant increase in both macrophage ( Figure 6A ) and neutrophil Figure 6C ), an enzyme that directly contributes to the oxidative stress and endothelial dysfunction characteristics of atherosclerosis. 36 Indeed, increased chlorinated tyrosine ( Figure 6D ) and nitrosylated tyrosine ( Figure 6E ) immunoreactivities, indicative of myeloperoxidase-induced and oxidative stress-induced reactive oxygen and reactive nitrogen species, respectively, were observed in the lesion areas of myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice.
Discussion
The importance of KLF2 in cell quiescence, trafficking, and differentiation has been demonstrated in several cell types, including T lymphocytes, adipocytes, monocytes, and erythroid cells. 15, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] The role of KLF2 in the vascular system was documented by observations that mice lacking the KLF2 gene die in utero due to vascular abnormalities. 1,2 Endothelial specific KLF2 knockout mice are also embryonically lethal, thus establishing the importance of endothelial KLF2 expression in vascular functions. 3 Mice with hemizygous deficiency of KLF2 have been shown to augment atherosclerosis in apoE-deficient mice. 4 The latter study showed that increased atherosclerosis due to heterozygous KLF2 deficiency was due to elevated macrophage infiltration into the atherosclerotic lesion areas as well as increased oxidized LDL accumulation in the macrophages of the Klf2 Ϯ mice. 4 Because KLF2 expression in the hemizygous mice is reduced in all tissues, including endothelial cells of the vessel wall and leukocytes in circulation, the cell type responsible for the accelerated atherosclerosis in the Klf2 Ϯ mice has not been identified. The current study used conditional gene knockout approach to establish the importance of KLF2 expression in myeloid cell lineage in atheroprotection. The data revealed myeloid-specific KLF2 inactivation increases atherosclerosis in hypercholesterolemic Ldlr Ϫ/Ϫ mice. The mechanism appears to be related to increased myeloid cell adhesion to endothelial cells, with the consequence of elevated macrophage and neutrophil accumulation in atherosclerotic lesion areas to promote oxidative stress.
Although our results of increased atherosclerosis with myeloid-specific KLF2 inactivation are consistent with results reported earlier with hemizygous Klf2 Ϯ mice, the two studies differed with respect to macrophage lipid accumulation in vitro. Atkins et al showed that peritoneal macrophages isolated from hemizygous Klf2 Ϯ mice accumulated more neutral lipids accompanied by elevated fatty acid binding protein 4 expression in response to oxidized LDL. 4 In contrast, our results showed that peritoneal macrophages with total KLF2 deficiency were similar to control macrophage in lipid accumulation in response to acetylated LDL stimulation. Differences between these two studies are not immediately evident but may be related to KLF2 expression levels in the macrophages or due to different forms of modified lipoproteins used in the in vitro experiments. Additionally, although both our study with conditional myeloid-specific KLF2 knockout mice and the Atkins study 4 with global hemizygous Klf2 Ϯ mice showed increased atherosclerosis with elevated macrophage infiltration into the lesion areas, our data additionally indicated that KLF2 expression in macrophages is not the only contributing factor, with KLF2 expression in neutrophils also playing prominent role in accounting for the difference in atherosclerosis between control and KLF2-deficient mice.
It is interesting to note that in comparison to control macrophages, KLF2-deficient macrophages expressed less IL-6 and iNOS in response to LPS-induced M1 polarization, yet more atherosclerosis was observed in myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice compared with myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ mice. Although lower levels of inflammatory M1 markers are typically associated with less atherosclerosis, 47 the robust atheroscle- 
rosis observed in myeKlf2
Ϫ/Ϫ Ldlr Ϫ/Ϫ mice may be due to more myeKlf2 Ϫ/Ϫ macrophages recruited to the atherosclerotic lesion areas as a consequence of increased CD11b expression and their adhesion to endothelial cells. Alternatively, the myeKlf2 Ϫ/Ϫ macrophages were also less polarized to M2 macrophages with reduced Fizz1 expression in response to IL-4, suggesting their reduced ability to resolve inflammation at the lesion site. 48 Our results showing persistent presence of significantly more neutrophils in the lesion areas of myeKlf2 Ϫ/Ϫ mice compared with myeKlf2 ϩ/ϩ mice is consistent with the latter possibility. Typically, neutrophils are prominent in atherosclerotic lesions only during the early phase of atherogenesis preceding the recruitment of macrophages and the establishment of mature plaques. 49 However, significant presence of neutrophils was observed in hypercholesterolemic myeKlf2 Ϫ/Ϫ mice even after 8 weeks of feeding the high fat and high cholesterol diet when mature lesions were well established. The high levels of neutrophils in the atherosclerotic plaques of myeKlf2 Ϫ/Ϫ mice may also reflect increased CD11b expression in myeKlf2 Ϫ/Ϫ neutrophils, leading to their sustained infiltration into atherosclerotic lesion areas throughout the atherosclerosis process.
Results of the current study also showed that myeKlf2 Ϫ/Ϫ mice have reduced lymphocyte cell count in the blood. Because the LysM promoter sequence used in the current study to drive cre expression and conditional Klf2 knockout is specific for myeloid cells without direct influence on gene expression in lymphoid cells, 50 the reduced number of lymphocytes in myeKlf2 Ϫ/Ϫ mice is probably an indirect effect reflecting myeloid cell regulation of lymphopoiesis. 27, 51 However, despite the contributing role of lymphocytes in vascular inflammation and atherosclerosis, 52 the reduction in the number of lymphocytes in circulation of myeKlf2 Ϫ/Ϫ mice did not reduce atherosclerosis in hypercholesterolemic Ldlr Ϫ/Ϫ mice. In contrast, atherosclerosis was significantly increased in myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice compared with myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ mice. The difference is likely due to elevated macrophage and neutrophil adhesion to activated endothelial cells and their infiltration into the atherosclerotic lesion areas. The contributory role of neutrophils toward atherosclerosis progression is recently highlighted by data showing neutrophilia promotes atherosclerosis, whereas neutropenia reduces atherosclerosis. 53 Neutrophil accumulation in the vessel wall may increase atherosclerosis through its abundant expression of myeloperoxidase, which promotes endothelial dysfunction and elevates oxidative stress. 36, 54 Increases in myeloperoxidase as well as reactive oxygen and nitrogen species were indeed observed in the lesion areas of myeKlf2 Ϫ/Ϫ Ldlr Ϫ/Ϫ mice compared with myeKlf2 ϩ/ϩ Ldlr Ϫ/Ϫ mice. In view of reports showing that statin induces KLF2 expression in several cell types, [55] [56] [57] including its reduction of CD11b expression 58, 59 and transendothelial migration of leukocytes in the vessel wall, 60 -63 the cholesterol-independent properties of statin in atheroprotection may in part be related to induction of KLF2 expression in macrophages and neutrophils, leading to their reduced adherence to activated endothelial cells.
